DrugPatentWatch Database Preview
Details for Patent: 8,486,973
» See Plans and Pricing
Which drugs does patent 8,486,973 protect, and when does it expire?
Patent 8,486,973 protects SUBSYS and is included in one NDA.
This patent has nine patent family members in nine countries.
Summary for Patent: 8,486,973
Title: | Sublingual fentanyl spray |
Abstract: | The present invention is directed to sublingual formulations containing fentanyl, a pharmaceutically acceptable salt thereof, or derivative thereof, suitable for administration to a patient, and methods for treatment with the formulations. |
Inventor(s): | Kottayil; S. George (Phoenix, AZ), Goskonda; Venkat R. (Gurnee, IL), Zhu; Zhongyuan (Vernon Hills, IL), Kattookaran; Linet (Des Plaines, IL), Parikh; Neha (Chicago, IL) |
Assignee: | Insys Therapeutics, Inc. (Phoenix, AZ) |
Application Number: | 12/221,333 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,486,973 |
Patent Claim Types: see list of patent claims | Use; Formulation; Composition; Delivery; Device; |
Drugs Protected by US Patent 8,486,973
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Btcp Pharma | SUBSYS | fentanyl | SPRAY;SUBLINGUAL | 202788-001 | Jan 4, 2012 | RX | Yes | No | Start Trial | Start Trial | Start Trial | |||||
Btcp Pharma | SUBSYS | fentanyl | SPRAY;SUBLINGUAL | 202788-002 | Jan 4, 2012 | RX | Yes | No | Start Trial | Start Trial | Start Trial | |||||
Btcp Pharma | SUBSYS | fentanyl | SPRAY;SUBLINGUAL | 202788-003 | Jan 4, 2012 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | |||||
Btcp Pharma | SUBSYS | fentanyl | SPRAY;SUBLINGUAL | 202788-004 | Jan 4, 2012 | RX | Yes | No | Start Trial | Start Trial | Start Trial | |||||
Btcp Pharma | SUBSYS | fentanyl | SPRAY;SUBLINGUAL | 202788-005 | Jan 4, 2012 | RX | Yes | No | Start Trial | Start Trial | Start Trial | |||||
Btcp Pharma | SUBSYS | fentanyl | SPRAY;SUBLINGUAL | 202788-006 | Aug 30, 2012 | RX | Yes | No | Start Trial | Start Trial | Start Trial | |||||
Btcp Pharma | SUBSYS | fentanyl | SPRAY;SUBLINGUAL | 202788-007 | Aug 30, 2012 | RX | Yes | No | Start Trial | Start Trial | Start Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,486,973
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2008282743 | Start Trial | |||
Canada | 2698749 | Start Trial | |||
Denmark | 2180844 | Start Trial | |||
European Patent Office | 2180844 | Start Trial | |||
Spain | 2668366 | Start Trial | |||
Norway | 2180844 | Start Trial | |||
Poland | 2180844 | Start Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |